TY - JOUR AU - Wiemken, T. L. AU - Peyrani, P. AU - Ramirez, J. A. PY - 2012 DA - 2012// TI - Global changes in the epidemiology of community-acquired pneumonia JO - Semin Respir Crit Care Med VL - 33 UR - https://doi.org/10.1055/s-0032-1315633 DO - 10.1055/s-0032-1315633 ID - Wiemken2012 ER - TY - JOUR AU - Polverino, E. AU - Torres, M. A. PY - 2011 DA - 2011// TI - Community-acquired pneumonia JO - Minerva Anestesiol VL - 77 ID - Polverino2011 ER - TY - JOUR AU - Almirall, J. AU - Bolibar, I. AU - Vidal, J. AU - Sauca, G. AU - Coll, P. AU - Niklasson, B. AU - Bartolome, M. AU - Balanzo, X. PY - 2000 DA - 2000// TI - Epidemiology of community-acquired pneumonia in adults: a population-based study JO - Eur Respir J VL - 15 UR - https://doi.org/10.1034/j.1399-3003.2000.15d21.x DO - 10.1034/j.1399-3003.2000.15d21.x ID - Almirall2000 ER - TY - JOUR AU - El Moussaoui, R. AU - Opmeer, B. C. AU - de Borgie, C. A. AU - Nieuwkerk, P. AU - Bossuyt, P. M. AU - Speelman, P. AU - Prins, J. M. PY - 2006 DA - 2006// TI - Long-term symptom recovery and health-related quality of life in patients with mild-to-moderate-severe community-acquired pneumonia JO - Chest VL - 130 UR - https://doi.org/10.1378/chest.130.4.1165 DO - 10.1378/chest.130.4.1165 ID - El Moussaoui2006 ER - TY - JOUR AU - Lim, W. S. AU - Baudouin, S. V. AU - George, R. C. AU - Hill, A. T. AU - Jamieson, C. AU - Le Jeune, I. AU - Macfarlane, J. T. AU - Read, R. C. AU - Roberts, H. J. AU - Levy, M. L. AU - Wani, M. AU - Woodhead, M. A. PY - 2009 DA - 2009// TI - BTS guidelines for the management of community acquired pneumonia in adults: update 2009 JO - Thorax VL - 64 UR - https://doi.org/10.1136/thx.2009.121434 DO - 10.1136/thx.2009.121434 ID - Lim2009 ER - TY - JOUR AU - Lim, W. S. AU - Woodhead, M. PY - 2011 DA - 2011// TI - British thoracic society adult community acquired pneumonia audit 2009/10 JO - Thorax VL - 66 UR - https://doi.org/10.1136/thoraxjnl-2011-200081 DO - 10.1136/thoraxjnl-2011-200081 ID - Lim2011 ER - TY - JOUR AU - Lode, H. M. PY - 2007 DA - 2007// TI - Managing community-acquired pneumonia: a European perspective JO - Respir Med VL - 101 UR - https://doi.org/10.1016/j.rmed.2007.04.008 DO - 10.1016/j.rmed.2007.04.008 ID - Lode2007 ER - TY - JOUR AU - Watkins, R. R. AU - Lemonovich, T. L. PY - 2011 DA - 2011// TI - Diagnosis and management of community-acquired pneumonia in adults JO - Am Fam Physician VL - 83 ID - Watkins2011 ER - TY - JOUR AU - Welte, T. AU - Torres, A. AU - Nathwani, D. PY - 2012 DA - 2012// TI - Clinical and economic burden of community-acquired pneumonia among adults in Europe JO - Thorax VL - 67 UR - https://doi.org/10.1136/thx.2009.129502 DO - 10.1136/thx.2009.129502 ID - Welte2012 ER - TY - JOUR AU - Nair, G. B. AU - Niederman, M. S. PY - 2011 DA - 2011// TI - Community-acquired pneumonia: an unfinished battle JO - Med Clin North Am VL - 95 UR - https://doi.org/10.1016/j.mcna.2011.08.007 DO - 10.1016/j.mcna.2011.08.007 ID - Nair2011 ER - TY - JOUR AU - Jackson, M. L. AU - Neuzil, K. M. AU - Thompson, W. W. AU - Shay, D. K. AU - Yu, O. AU - Hanson, C. A. AU - Jackson, L. A. PY - 2004 DA - 2004// TI - The burden of community-acquired pneumonia in seniors: results of a population-based study JO - Clin Infect Dis VL - 39 UR - https://doi.org/10.1086/425615 DO - 10.1086/425615 ID - Jackson2004 ER - TY - JOUR AU - Howard, L. S. AU - Sillis, M. AU - Pasteur, M. C. AU - Kamath, A. V. AU - Harrison, B. D. PY - 2005 DA - 2005// TI - Microbiological profile of community-acquired pneumonia in adults over the last 20 years JO - J Infect VL - 50 UR - https://doi.org/10.1016/j.jinf.2004.05.003 DO - 10.1016/j.jinf.2004.05.003 ID - Howard2005 ER - TY - JOUR AU - Lieberman, D. AU - Schlaeffer, F. AU - Boldur, I. AU - Lieberman, D. AU - Horowitz, S. AU - Friedman, M. G. AU - Leiononen, M. AU - Horovitz, O. PY - 1996 DA - 1996// TI - Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients JO - Thorax VL - 51 UR - https://doi.org/10.1136/thx.51.2.179 DO - 10.1136/thx.51.2.179 ID - Lieberman1996 ER - TY - JOUR AU - Shah, B. A. AU - Singh, G. AU - Naik, M. A. AU - Dhobi, G. N. PY - 2010 DA - 2010// TI - Bacteriological and clinical profile of community acquired pneumonia in hospitalized patients JO - Lung India VL - 27 UR - https://doi.org/10.4103/0970-2113.63606 DO - 10.4103/0970-2113.63606 ID - Shah2010 ER - TY - JOUR AU - Mandell, L. A. AU - Wunderink, R. G. AU - Anzueto, A. AU - Bartlett, J. G. AU - Campbell, G. D. AU - Dean, N. C. AU - Dowell, S. F. AU - File, T. M. AU - Musher, D. M. AU - Niederman, M. S. AU - Torres, A. AU - Whitney, C. G. PY - 2007 DA - 2007// TI - Infectious diseases society of America/American thoracic society consensus guidelines on the management of community-acquired pneumonia in adults JO - Clin Infect Dis VL - 44 UR - https://doi.org/10.1086/511159 DO - 10.1086/511159 ID - Mandell2007 ER - TY - JOUR AU - Woodhead, M. AU - Blasi, F. AU - Ewig, S. AU - Garau, J. AU - Huchon, G. AU - Ieven, M. AU - Ortqvist, A. AU - Schaberg, T. AU - Torres, A. AU - van der Heijden, G. AU - Read, R. AU - Verheij, T. J. PY - 2011 DA - 2011// TI - Guidelines for the management of adult lower respiratory tract infections - full version JO - Clin Microbiol Infect VL - 17 UR - https://doi.org/10.1111/j.1469-0691.2011.03672.x DO - 10.1111/j.1469-0691.2011.03672.x ID - Woodhead2011 ER - TY - JOUR AU - Blondeau, J. M. AU - Vaughan, D. AU - Laskowski, R. AU - Borsos, S. PY - 2001 DA - 2001// TI - Susceptibility of Canadian isolates of Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumoniae to oral antimicrobial agents JO - Int J Antimicrob Agents VL - 17 UR - https://doi.org/10.1016/S0924-8579(01)00334-X DO - 10.1016/S0924-8579(01)00334-X ID - Blondeau2001 ER - TY - JOUR AU - Burkhardt, O. AU - Welte, T. PY - 2009 DA - 2009// TI - 10 years’ experience with the pneumococcal quinolone moxifloxacin JO - Expert Rev Anti Infect Ther VL - 7 UR - https://doi.org/10.1586/eri.09.46 DO - 10.1586/eri.09.46 ID - Burkhardt2009 ER - TY - JOUR AU - Miravitlles, M. PY - 2005 DA - 2005// TI - Moxifloxacin in respiratory tract infections JO - Expert Opin Pharmacother VL - 6 UR - https://doi.org/10.1517/14656566.6.2.283 DO - 10.1517/14656566.6.2.283 ID - Miravitlles2005 ER - TY - JOUR AU - Miravitlles, M. AU - Anzueto, A. PY - 2008 DA - 2008// TI - Moxifloxacin: a respiratory fluoroquinolone JO - Expert Opin Pharmacother VL - 9 UR - https://doi.org/10.1517/14656566.9.10.1755 DO - 10.1517/14656566.9.10.1755 ID - Miravitlles2008 ER - TY - JOUR AU - An, M. M. AU - Zou, Z. AU - Shen, H. AU - Gao, P. H. AU - Cao, Y. B. AU - Jiang, Y. Y. PY - 2010 DA - 2010// TI - Moxifloxacin monotherapy versus β-lactam-based standard therapy for community-acquired pneumonia: a meta-analysis of randomised controlled trials JO - Int J Antimicrob Agents VL - 36 UR - https://doi.org/10.1016/j.ijantimicag.2010.03.010 DO - 10.1016/j.ijantimicag.2010.03.010 ID - An2010 ER - TY - JOUR AU - Anzueto, A. AU - Niederman, M. S. AU - Pearle, J. AU - Restrepo, M. I. AU - Heyder, A. AU - Choudhri, S. H. PY - 2006 DA - 2006// TI - Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy JO - Clin Infect Dis VL - 42 UR - https://doi.org/10.1086/498520 DO - 10.1086/498520 ID - Anzueto2006 ER - TY - JOUR AU - Finch, R. AU - Schurmann, D. AU - Collins, O. AU - Collins, O. AU - Kubin, R. AU - McGivern, J. AU - Bobbaers, H. AU - Izquierdo, J. L. AU - Nikolaides, P. AU - Ogundare, F. AU - Raz, R. AU - Zuck, P. AU - Hoeffken, G. PY - 2002 DA - 2002// TI - Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatment JO - Antimicrob Agents Chemother VL - 46 UR - https://doi.org/10.1128/AAC.46.6.1746-1754.2002 DO - 10.1128/AAC.46.6.1746-1754.2002 ID - Finch2002 ER - TY - JOUR AU - Fogarty, C. AU - Grossman, C. AU - Williams, J. AU - Haverstock, D. AU - Church, D. PY - 1999 DA - 1999// TI - Efficacy and safety of moxifloxacin vs. clarithromycin for community-acquired pneumonia JO - Infect Med VL - 16 ID - Fogarty1999 ER - TY - JOUR AU - Fogarty, C. AU - Torres, A. AU - Choudhri, S. AU - Haverstock, D. AU - Herrington, J. AU - Ambler, J. PY - 2005 DA - 2005// TI - Efficacy of moxifloxacin for treatment of penicillin-, macrolide- and multidrug-resistant Streptococcus pneumoniae in community-acquired pneumonia JO - Int J Clin Pract VL - 59 UR - https://doi.org/10.1111/j.1368-5031.2005.00699.x DO - 10.1111/j.1368-5031.2005.00699.x ID - Fogarty2005 ER - TY - JOUR AU - Hoeffken, G. AU - Meyer, H. P. AU - Winter, J. AU - Verhoef, L. PY - 2001 DA - 2001// TI - The efficacy and safety of two oral moxifloxacin regimens compared to oral clarithromycin in the treatment of community-acquired pneumonia JO - Respir Med VL - 95 UR - https://doi.org/10.1053/rmed.2001.1113 DO - 10.1053/rmed.2001.1113 ID - Hoeffken2001 ER - TY - JOUR AU - Petitpretz, P. AU - Arvis, P. AU - Marel, M. AU - Moita, J. AU - Urueta, J. PY - 2001 DA - 2001// TI - Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adults JO - Chest VL - 119 UR - https://doi.org/10.1378/chest.119.1.185 DO - 10.1378/chest.119.1.185 ID - Petitpretz2001 ER - TY - JOUR AU - Portier, H. AU - Brambilla, C. AU - Garre, M. AU - Paganin, F. AU - Poubeau, P. AU - Zuck, P. PY - 2005 DA - 2005// TI - Moxifloxacin monotherapy compared to amoxicillin-clavulanate plus roxithromycin for nonsevere community-acquired pneumonia in adults with risk factors JO - Eur J Clin Microbiol Infect Dis VL - 24 UR - https://doi.org/10.1007/s10096-005-1347-1 DO - 10.1007/s10096-005-1347-1 ID - Portier2005 ER - TY - JOUR AU - Torres, A. AU - Garau, J. AU - Arvis, P. AU - Carlet, J. AU - Choudhri, S. AU - Kureishi, A. AU - Le Berre, M. A. AU - Lode, H. AU - Winter, J. AU - Read, R. C. PY - 2008 DA - 2008// TI - Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study – a randomized clinical trial JO - Clin Infect Dis VL - 46 UR - https://doi.org/10.1086/587519 DO - 10.1086/587519 ID - Torres2008 ER - TY - JOUR AU - Torres, A. AU - Muir, J. F. AU - Corris, P. AU - Kubin, R. AU - Duprat-Lomon, I. AU - Sagnier, P. P. AU - Hoffken, G. PY - 2003 DA - 2003// TI - Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumonia JO - Eur Respir J VL - 21 UR - https://doi.org/10.1183/09031936.03.00045202 DO - 10.1183/09031936.03.00045202 ID - Torres2003 ER - TY - JOUR AU - Welte, T. AU - Petermann, W. AU - Schurmann, D. AU - Bauer, T. T. AU - Reimnitz, P. PY - 2005 DA - 2005// TI - Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy JO - Clin Infect Dis VL - 41 UR - https://doi.org/10.1086/498149 DO - 10.1086/498149 ID - Welte2005 ER - TY - JOUR AU - Yuan, X. AU - Liang, B. B. AU - Wang, R. AU - Liu, Y. N. AU - Sun, C. G. AU - Cai, Y. AU - Yu, X. H. AU - Bai, N. AU - Zhao, T. M. AU - Cui, J. C. AU - Chen, L. A. PY - 2012 DA - 2012// TI - Treatment of community-acquired pneumonia with moxifloxacin: a meta-analysis of randomized controlled trials JO - J Chemother VL - 24 UR - https://doi.org/10.1179/1973947812Y.0000000028 DO - 10.1179/1973947812Y.0000000028 ID - Yuan2012 ER - TY - JOUR AU - Ball, P. AU - Stahlmann, R. AU - Kubin, R. AU - Choudhri, S. AU - Owens, R. PY - 2004 DA - 2004// TI - Safety profile of oral and intravenous moxifloxacin: cumulative data from clinical trials and postmarketing studies JO - Clin Ther VL - 26 UR - https://doi.org/10.1016/S0149-2918(04)90170-1 DO - 10.1016/S0149-2918(04)90170-1 ID - Ball2004 ER - TY - JOUR AU - Drummond, M. F. AU - Becker, D. L. AU - Hux, M. AU - Chancellor, J. V. AU - Duprat-Lomon, I. AU - Kubin, R. AU - Sagnier, P. P. PY - 2003 DA - 2003// TI - An economic evaluation of sequential i.v./po moxifloxacin therapy compared to i.v./po co-amoxiclav with or without clarithromycin in the treatment of community-acquired pneumonia JO - Chest VL - 124 UR - https://doi.org/10.1378/chest.124.2.526 DO - 10.1378/chest.124.2.526 ID - Drummond2003 ER - TY - JOUR AU - Ferrara, A. M. PY - 2007 DA - 2007// TI - A brief review of moxifloxacin in the treatment of elderly patients with community-acquired pneumonia (CAP) JO - Clin Interv Aging VL - 2 ID - Ferrara2007 ER - TY - JOUR AU - Concato, J. AU - Shah, N. AU - Horwitz, R. I. PY - 2000 DA - 2000// TI - Randomized, controlled trials, observational studies, and the hierarchy of research designs JO - N Engl J Med VL - 342 UR - https://doi.org/10.1056/NEJM200006223422507 DO - 10.1056/NEJM200006223422507 ID - Concato2000 ER - TY - JOUR AU - Bauer, T. T. AU - Ewig, S. AU - Marre, R. AU - Suttorp, N. AU - Welte, T. PY - 2006 DA - 2006// TI - CRB-65 predicts death from community-acquired pneumonia JO - J Intern Med VL - 260 UR - https://doi.org/10.1111/j.1365-2796.2006.01657.x DO - 10.1111/j.1365-2796.2006.01657.x ID - Bauer2006 ER - TY - JOUR AU - Bont, J. AU - Hak, E. AU - Hoes, A. W. AU - Macfarlane, J. T. AU - Verheij, T. J. PY - 2008 DA - 2008// TI - Predicting death in elderly patients with community-acquired pneumonia: a prospective validation study reevaluating the CRB-65 severity assessment tool JO - Arch Intern Med VL - 168 UR - https://doi.org/10.1001/archinte.168.13.1465 DO - 10.1001/archinte.168.13.1465 ID - Bont2008 ER - TY - JOUR AU - Capelastegui, A. AU - Espana, P. P. AU - Quintana, J. M. AU - Areitio, I. AU - Gorordo, I. AU - Egurrola, M. AU - Bilbao, A. PY - 2006 DA - 2006// TI - Validation of a predictive rule for the management of community-acquired pneumonia JO - Eur Respir J VL - 27 UR - https://doi.org/10.1183/09031936.06.00062505 DO - 10.1183/09031936.06.00062505 ID - Capelastegui2006 ER - TY - JOUR AU - Lim, W. S. AU - van der Eerden, M. M. AU - Laing, R. AU - Boersma, W. G. AU - Karalus, N. AU - Town, G. I. AU - Lewis, S. A. AU - Macfarlane, J. T. PY - 2003 DA - 2003// TI - Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study JO - Thorax VL - 58 UR - https://doi.org/10.1136/thorax.58.5.377 DO - 10.1136/thorax.58.5.377 ID - Lim2003 ER - TY - JOUR AU - Man, S. Y. AU - Lee, N. AU - Ip, M. AU - Antonio, G. E. AU - Chau, S. S. AU - Mak, P. AU - Graham, C. A. AU - Zhang, M. AU - Lui, G. AU - Chan, P. K. AU - Ahuja, A. T. AU - Hui, D. S. AU - Sung, J. J. AU - Rainer, T. H. PY - 2007 DA - 2007// TI - Prospective comparison of three predictive rules for assessing severity of community-acquired pneumonia in Hong Kong JO - Thorax VL - 62 UR - https://doi.org/10.1136/thx.2006.069740 DO - 10.1136/thx.2006.069740 ID - Man2007 ER - TY - JOUR AU - Zuberi, F. F. AU - Khan, J. A. PY - 2008 DA - 2008// TI - Prospective comparison of prediction rules of mortality risk for CAP in a developing country JO - Int J Tuberc Lung Dis VL - 12 ID - Zuberi2008 ER - TY - JOUR AU - Al-Marzouki, S. AU - Evans, S. AU - Marshall, T. AU - Roberts, I. PY - 2005 DA - 2005// TI - Are these data real? Statistical methods for the detection of data fabrication in clinical trials JO - BMJ VL - 331 UR - https://doi.org/10.1136/bmj.331.7511.267 DO - 10.1136/bmj.331.7511.267 ID - Al-Marzouki2005 ER - TY - CHAP PY - 2014 DA - 2014// BT - ENCePP Guide on Methodological Standards in Pharmacoepidemiology ID - ref44 ER - TY - CHAP PY - 2013 DA - 2013// BT - Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring ID - ref45 ER - TY - JOUR AU - Weir, C. AU - Murray, G. PY - 2011 DA - 2011// TI - Fraud in clinical trials: detecting it and preventing it JO - Significance VL - 8 UR - https://doi.org/10.1111/j.1740-9713.2011.00521.x DO - 10.1111/j.1740-9713.2011.00521.x ID - Weir2011 ER - TY - JOUR AU - Malathum, K. AU - Singh, K. V. AU - Murray, B. E. PY - 1999 DA - 1999// TI - In vitro activity of moxifloxacin, a new 8-methoxyquinolone, against gram-positive bacteria JO - Diagn Microbiol Infect Dis VL - 35 UR - https://doi.org/10.1016/S0732-8893(99)00065-6 DO - 10.1016/S0732-8893(99)00065-6 ID - Malathum1999 ER - TY - JOUR AU - Soman, A. AU - Honeybourne, D. AU - Andrews, J. AU - Jevons, G. AU - Wise, R. PY - 1999 DA - 1999// TI - Concentrations of moxifloxacin in serum and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopy JO - J Antimicrob Chemother VL - 44 UR - https://doi.org/10.1093/jac/44.6.835 DO - 10.1093/jac/44.6.835 ID - Soman1999 ER - TY - STD TI - AVELOX® (Moxifloxacin Hydrochloride) [Summary of Product Characteristics] Solution for Infusion. 2012, EMA, Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Avalox_29/WC500090584.pdf. Accessed July 16, 2014 UR - http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Avalox_29/WC500090584.pdf ID - ref49 ER - TY - STD TI - AVELOX® (Moxifloxacin Hydrochloride) [Summary of Product Characteristics] Tablets. 2012, EMA, Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Avelox_6_12/WC500013020.pdf. Accessed July 16, 2014 UR - http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Avelox_6_12/WC500013020.pdf ID - ref50 ER - TY - JOUR AU - Dwyer, R. AU - Hedlund, J. AU - Darenberg, J. AU - Henriques-Normark, B. AU - Naucler, P. AU - Runesdotter, S. AU - Kalin, M. PY - 2011 DA - 2011// TI - Improvement of CRB-65 as a prognostic scoring system in adult patients with bacteraemic pneumococcal pneumonia JO - Scand J Infect Dis VL - 43 UR - https://doi.org/10.3109/00365548.2011.562529 DO - 10.3109/00365548.2011.562529 ID - Dwyer2011 ER - TY - JOUR AU - Ewig, S. AU - Bauer, T. AU - Richter, K. AU - Szenscenyi, J. AU - Heller, G. AU - Strauss, R. AU - Welte, T. PY - 2013 DA - 2013// TI - Prediction of in-hospital death from community-acquired pneumonia by varying CRB-age groups JO - Eur Respir J VL - 41 UR - https://doi.org/10.1183/09031936.00065212 DO - 10.1183/09031936.00065212 ID - Ewig2013 ER - TY - JOUR AU - Levy, M. L. AU - Le, J. I. AU - Woodhead, M. A. AU - Macfarlaned, J. T. AU - Lim, W. S. PY - 2010 DA - 2010// TI - Primary care summary of the British thoracic society guidelines for the management of community acquired pneumonia in adults: 2009 update. Endorsed by the Royal College of General Practitioners and the Primary Care Respiratory Society UK JO - Prim Care Respir J VL - 19 UR - https://doi.org/10.4104/pcrj.2010.00014 DO - 10.4104/pcrj.2010.00014 ID - Levy2010 ER - TY - JOUR AU - Bartlett, J. G. AU - Dowell, S. F. AU - Mandell, L. A. AU - File, T. M. AU - Musher, D. M. AU - Fine, M. J. PY - 2000 DA - 2000// TI - Practice guidelines for the management of community-acquired pneumonia in adults: infectious diseases society of America JO - Clin Infect Dis VL - 31 UR - https://doi.org/10.1086/313954 DO - 10.1086/313954 ID - Bartlett2000 ER - TY - JOUR AU - Lutfiyya, M. N. AU - Henley, E. AU - Chang, L. F. AU - Reyburn, S. W. PY - 2006 DA - 2006// TI - Diagnosis and treatment of community-acquired pneumonia JO - Am Fam Physician VL - 73 ID - Lutfiyya2006 ER - TY - JOUR AU - Ewig, S. AU - Hecker, H. AU - Suttorp, N. AU - Marre, R. AU - Welte, T. PY - 2011 DA - 2011// TI - Moxifloxacin monotherapy versus β-lactam mono- or combination therapy in hospitalized patients with community-acquired pneumonia JO - J Infect VL - 62 UR - https://doi.org/10.1016/j.jinf.2011.01.009 DO - 10.1016/j.jinf.2011.01.009 ID - Ewig2011 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2466/14/105/prepub UR - http://www.biomedcentral.com/1471-2466/14/105/prepub ID - ref57 ER -